Arrow Artboard Created with Sketch. Artboard Created with Sketch. Title Chevron Title Chevron Icon Facebook Icon Linkedin Icon Mail Contact Path Layer Icon Mail Positive Arrow Icon Print Articles Single-dose flu drug approved for sale in Japan Shionogi's virus-suppressing medication to rival Tamiflu It is hoped that Xofluza can bring down the costs of flu treatment and help control the spread of infection.
February 23, 2018 20:20 JST
TOKYO -- A drug that suppresses replication of the flu virus with a single oral dose has been approved for sale in Japan.
Shionogi on Friday announced that its Xofluza tablet had received approval from the Ministry of Health, Labour and Welfare. Take your reading anywhere with offline reading functions Never miss a story with breaking news alerts Customize your reading experience
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter
Free access for everyone - Sep. 30
Find out more
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
to learn how you can update your cookie settings.
Accept & Continue